RGNX Stock Analysis: Buy, Sell, or Hold?
RGNX - REGENXBIO Inc.
$9.04
0.13 (1.46%)
▲
5d:
-24.79%
30d:
-5.83%
90d:
+35.13%
WAIT
LOW Confidence
Analysis Updated: Aug 25, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When RGNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: RGNX is down 24.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: RGNX is down 24.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: RGNX is currently trading at $9.04, which is considered oversold relative to its 30-day fair value range of $9.54 to $11.09.
Technical Outlook: Technically, RGNX is in a downtrend. Immediate support is located at $7.77, while resistance sits at $12.08.
Market Sentiment: RGNX scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $23.91 (+168.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RGNX is in a downtrend. Immediate support is located at $7.77, while resistance sits at $12.08.
Market Sentiment: RGNX scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $23.91 (+168.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.54 -
$11.09
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (26/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 168.3% below Wall St target ($23.91)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.54 -
$11.09
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$7.77
Resistance Level
$12.08
Current Trend
Downtrend
Technical data as of
Aug 25, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.97
Wall Street Target
$23.91
(+168.3%)
Revenue Growth (YoY)
405.7%
Profit Margin
-112.6%
Share & Embed Analysis
Last updated: August 26, 2026 9:56 AM ET
Data refreshes hourly during market hours. Next update: 10:56 AM
Data refreshes hourly during market hours. Next update: 10:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RGNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Steve Pakola
SELL
5124 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 39 SELL |
|
EYPT
EyePoint, Inc |
STRONG BUY
13 analysts |
$27 | 52 HOLD |
